NCT03529929 is a Phase 3 clinical trial of Methylprednisolone in Aging, sponsored by Texas A&M University.

Who is sponsoring NCT03529929?

NCT03529929 is sponsored by Texas A&M University.

What drugs are being tested in NCT03529929?

Interventions in NCT03529929: Methylprednisolone.

Is NCT03529929 still recruiting?

NCT03529929 is currently withdrawn. Last updated 11 March 2020.

Last reviewed 2020-03-11 · How we verify

NCT03529929

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Glucocorticoid Inflammation Paradox in Human Skeletal Muscle

Withdrawn Phase 3 Last updated 11 March 2020

What this trial tests

Phase 3 trial testing Methylprednisolone in Aging. Withdrawn.

Timeline

1 June 2019

Primary endpoint
1 May 2020

1 December 2020

Quick facts

Lead sponsor	Texas A&M University
Phase	Phase 3
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Start date	1 June 2019
Primary completion	1 May 2020
Estimated completion	1 December 2020
Sites	1 location across United States

Drugs / interventions tested

Methylprednisolone (methylprednisolone) — full drug profile →

Conditions studied

Aging — all drugs for Aging →

Sponsor

Texas A&M University

Who can join

Adults 60 to 80, any sex, with Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this project, we propose to investigate the metabolic consequences of glucocorticoid therapy, given orally as a 6 day Medrol Dose pack, on human skeletal muscle as measured by western blotting and PCR and skeletal muscle mitochondrial capacity as measured by High-Resolution Respirometry in healthy individuals. Medrol is an FDA approved drug with many clinical indications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Methylprednisolone

Trials testing the same drug.

NCT07072585 — Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leuk · Phase 2, PHASE3 · not yet recruiting
NCT07455396 — Pediatric Asthma Trial of Corticosteroid Heterogeneity (PATCH): Trial of Dexamethasone Versus Methylprednisolone for Ped · Phase 2 · not yet recruiting
NCT07507643 — A Study of Methylprednisolone in People Having Liver Surgery · Phase 3 · recruiting
NCT07357935 — Early Inflammatory-Immune Stratification and Precision Glucocorticoid Intervention in Acute Respiratory Failure Induced · Phase 1, PHASE2 · not yet recruiting
NCT07265258 — A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease · Phase 4 · not yet recruiting

Other recruiting trials for Aging

Currently open trials in the same condition.

NCT02831335 — Technical Development of Multi-Parametric Renocerebral MRI · recruiting
NCT07099053 — Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging · recruiting
NCT07504068 — Effects of Physical Exercise and a Nutritional Supplement on Body Composition, Metabolic Function, and Overall Health in · NA · recruiting
NCT07525453 — Effects of Three Different Exercise Programs on Dynamic Balance in Community-Dwelling Older Adults · NA · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Other Texas A&M University trials

Trials by the same sponsor.

NCT07079995 — Healthy School Recognized Campus: A Hybrid Type 2 Implementation-Effectiveness Trial · NA · recruiting
NCT06950775 — The Neighborhood & Health Study · recruiting
NCT06890689 — Effectiveness of Scaling and Root Planing in Deeper Pockets · active not recruiting
NCT06797089 — Does myTAP Oral Appliance Therapy Including a Mouth Shield Lessen Periodontitis in Mouth-Breathers Who Snore? · NA · completed
NCT05959434 — Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and PTSD · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03529929 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Texas A&M University
Last refreshed: 11 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03529929.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing